Intragastric Balloon Market By Type (Single Balloon, Dual Balloon, and Triple Balloon), By Application (Hosptials, Ambulatory Surgical Centres, and Clinics), and By Region - Market Trends, Analysis, and Forecast till 2030

Intragastric Balloon Market accounted for USD 14.2 Million in 2020 and is estimated to be USD 42.24 Million by 2030 and is anticipated to register a CAGR of 11.5%

Gastric balloons constructed of soft biocompatible silicone material that are filled with sterile saline solutions or gas are known as intragastric balloons. Through a non-surgical endoscopic procedure, they are placed into the stomach. When an intragastric balloon is inflated, the capacity of the stomach is reduced, making a person feel filled faster and for longer. It would also result in a reduction in the amount of food consumed. This therapy is available to overweight and obese individuals with a BMI of 30 to 70 who are not candidates for weight loss surgery. To ensure the effectiveness of the intragastric balloon surgery, permanent healthy dietary and exercise adjustments are essential. The main benefit of this therapy is that it helps to avoid the risks that come with surgical procedures. However, it has a few drawbacks, including the fact that not all patients tolerate it and the danger of nausea and vomiting. If a patient does not follow the food and exercise plan, the balloons may cause weight loss to fail.

Obesity is a major factor driving the market

Obesity is a huge health issue that affects people all over the world. Over the forecast period, the obesity epidemic is expected to continue to worsen, supporting market growth. According to estimates from the World Health Organization (2016), about 2 billion people are overweight, with around 650 million of them being obese. Furthermore, it is predicted that by 2025, 2.7 billion people would be overweight, with 1.0 billion being obese. Despite the high incidence of obesity and healthcare professional widespread approval of weight-loss surgical treatments (such as gastric bypass and sleeve gastrectomy), only 1% to 2% of the obese population is eligible for these procedures, resulting in substantial obesity-related mortality. For instance, According to World Health Organization figures, approximately 2.8 million people worldwide die each year as a result of obesity or overweight. This high death rate is expected to increase demand for less invasive techniques like an intragastric balloon. In 2017, the American Society for Metabolic and Bariatric Surgery (ASMBS) added the intragastric balloon to its list of approved procedures and devices as a therapeutic option. The ASMBS' approval and recommendation of this treatment is expected to boost the use of intragastric balloons.

The global intragastric balloon market report segments the market on the basis of type, application, and region.

Based on Type, Global Intragastric Balloon Market is segmented into Single Balloon, Dual Balloon, and Triple Balloon. Based on Application, Global Intragastric Balloon Market is segmented into Hosptials, Ambulatory Surgical Centres, and Clinics. 

Regional Insights:

Based on the region the global intragastric balloon market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In the intragastric balloons market, North America dominated the market due to  high prevalence of obesity, the availability of trained specialists, and the widespread use of weight reduction treatments are all contributing to the market's growth in this region. Over the projected period, the intragastric balloon market in Asia Pacific is expected to grow at a quick pace. Some of the primary drivers driving the market in this region include an increase in the number of obese people, a rise in unhealthy lifestyles, and the availability of therapy at a reasonable cost.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global intragastric balloon market report based on Type, Application and Region.                                                                                      

Global Intragastric Balloon Market, By Region:

• North America
  • • • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the intragastric balloon market are Allurion Technologies, Apollo Endosurgery, Districlass Medical SA, Endalis, Helioscopie Medical Implants, Lexel Srl, Life Partners Europe, Medicone, Medsil and Obalon Therapeutics Inc.

• Allurion Technologies
• Apollo Endosurgery
• Districlass Medical SA
• Endalis
• Helioscopie Medical Implants
• Lexel Srl
• Life Partners Europe
• Medicone
• Medsil and Obalon Therapeutics Inc.